QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$41.67 USD
-0.91 (-2.14%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $41.66 -0.01 (-0.02%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth C Momentum B VGM
Brokerage Reports
0 items in cart
QuidelOrtho Corporation [QDEL]
Reports for Purchase
Showing records 181 - 186 ( 186 total )
Company: QuidelOrtho Corporation
Industry: Medical - Products
Shares Revisiting 52 Week Low; Reiterating OUTPERFORM; - Greater Sell-Off Tees Up Easier Flu Trade; Fundamentals Ok
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Selloff Overdone; Upgrading to OUTPERFORM from NEUTRAL on Improved Risk/Reward for Next Flu Cycle; Resetting Estimates in the Process; Week 19 Flu Levels Weak As Usual.
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Company: QuidelOrtho Corporation
Industry: Medical - Products
Flu Sales Better Than Expected; Offset by Higher R&D Spend, Could Upset Stock?s Strong Fan Base; Lowering EPS Estimates a Tad; Reaffirming NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Flu Update & Earnings Preview: Flu Activity Remains Light; Ho Hum 1Q10 Expected; Stock Seems Disconnected from Earnings
Provider: WEDBUSH SECURITIES INC.
Analyst: KHURSHID Z
Company: QuidelOrtho Corporation
Industry: Medical - Products
Assuming Coverage with NEUTRAL Rating; On Sidelines Due to Near-term Earnings Risk & Until Greater Cost Clarity; Positive Long-Term Bias.
Provider: WEDBUSH SECURITIES INC.